NEW YORK--(BUSINESS WIRE)--Enzo Biochem Inc. (NYSE:ENZ) today reported results for the fiscal quarter and year ended July 31, 2015.
Fourth Quarter Highlights
• Revenues of $25.7 million were up 3% over the prior year quarter, despite decreased royalty income. Clinical Labs’ revenues of $17.2 million were up 11% over the same period in the prior year while Life Sciences product revenues were essentially unchanged on a constant currency basis.
Help employers find you! Check out all the jobs and post your resume.
